ABCA1 p.Thr1305Ala
Predicted by SNAP2: | A: N (72%), C: N (82%), D: N (57%), E: N (66%), F: D (71%), G: N (66%), H: N (57%), I: N (57%), K: N (61%), L: N (57%), M: N (72%), N: N (78%), P: N (61%), Q: N (72%), R: N (57%), S: N (82%), V: N (61%), W: D (75%), Y: D (71%), |
Predicted by PROVEAN: | A: N, C: N, D: N, E: N, F: D, G: N, H: D, I: N, K: N, L: N, M: N, N: N, P: N, Q: N, R: D, S: N, V: N, W: D, Y: D, |
[switch to compact view]
Comments [show]
None has been submitted yet.
[hide] Phosphorylation of a pest sequence in ABCA1 promot... J Biol Chem. 2003 Sep 26;278(39):37368-74. Epub 2003 Jul 17. Martinez LO, Agerholm-Larsen B, Wang N, Chen W, Tall AR
Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I.
J Biol Chem. 2003 Sep 26;278(39):37368-74. Epub 2003 Jul 17., [PMID:12869555]
Abstract [show]
ATP-binding cassette transporter A1 (ABCA1), the defective molecule in Tangier disease, mediates the apoAI-dependent efflux of excess cholesterol from cells. We recently showed that ABCA1 proteolysis by calpain was dependent on a PEST sequence in the cytoplasmic region of ABCA1 and was reversed by apoA-I interaction with ABCA1. We show here that phosphorylation of ABCA1 in HEK293 cells was reduced by 63 +/- 2.4% after removal of the PEST sequence (ABCA1delPEST) or by incubation of cells with apoAI (58 +/- 3.3%). By contrast, ABCA1delPEST showed no further decrease of phosphorylation upon apoAI treatment. To assess the hypothesis that PEST sequence phosphorylation could regulate ABCA1 calpain proteolysis, we mutagenized S/T residues in the PEST sequence and identified Thr-1286 and Thr-1305 as constitutively phosphorylated residues. The ABCA1-T1286A/T1305A mutant was not degraded by calpain and was not further stabilized upon apoA-I treatment. The T1286A/T1305A mutant showed a 3.1-fold increase in cell surface expression and a 2.3-fold increase of apoAI-mediated cholesterol efflux compared with wild type ABCA1. In conclusion, we propose a mechanism of regulation of ABCA1 cell surface expression and function in which the interaction with apoA-I results in dephosphorylation of the ABCA1 PEST sequence and thereby inhibits calpain degradation leading to an increase of ABCA1 cell surface expression.
Comments [show]
None has been submitted yet.
No. Sentence Comment
5 The ABCA1-T1286A/T1305A mutant was not degraded by calpain and was not further stabilized upon apoA-I treatment.
X
ABCA1 p.Thr1305Ala 12869555:5:17
status: NEW6 The T1286A/T1305A mutant showed a 3.1-fold increase in cell surface expression and a 2.3-fold increase of apoAI-mediated cholesterol efflux compared with wild type ABCA1.
X
ABCA1 p.Thr1305Ala 12869555:6:11
status: NEW31 mABCA1-FLAG mutation constructs were further called: MutAAAA for mutation to Ala on T1286A/S1296A/S1302A/T1305A, MutTAAT for mutation to Ala on S1296A/S1302A, and MutASSA for mutation to Ala on * This work was supported in part by National Institutes of Health Grant HL22682.
X
ABCA1 p.Thr1305Ala 12869555:31:105
status: NEW41 Printed in U.S.A. This paper is available on line at http://www.jbc.org T1286A/T1305A.
X
ABCA1 p.Thr1305Ala 12869555:41:81
status: NEW121 Mutation of Thr residues (1286 and 1305) decreases ABCA1 Phosphorylation. WT-mABCA1-FLAG, mABCA1delPEST-FLAG, mABCA1-FLAG mutated to Ala on T1286A/S1296A/S1302A/T1305A (MutAAAA), mutated to Ala on S1296A/S1302A (MutTAAT), or mutated to Ala on T1286A/T1305A (MutASSA), were transiently transfected in 6 wells of HEK-293 cells (2 g of plasmid DNA per well).
X
ABCA1 p.Thr1305Ala 12869555:121:161
status: NEWX
ABCA1 p.Thr1305Ala 12869555:121:250
status: NEW150 ABCA1 mutated on Thr-1286 and Thr-1305 is not degraded by calpain and is not stabilized by apoA-I. WT-mABCA1-FLAG or mABCA1-FLAG mutated to Ala on T1286A/T1305A (MutTSSA) were transiently transfected into HEK293 cells.
X
ABCA1 p.Thr1305Ala 12869555:150:154
status: NEW189 Effect of apigenin (CK2 inhibitor) and H-89 (PKA inhibitor) on ABCA1 phosphorylation. WT-mABCA1-FLAG or mABCA1-FLAG mutated to Ala on T1286A/T1305A (MutASSA) were transiently transfected in 6 wells of HEK-293 cells (2 g of plasmid DNA per well).
X
ABCA1 p.Thr1305Ala 12869555:189:141
status: NEW30 mABCA1-FLAG mutation constructs were further called: MutAAAA for mutation to Ala on T1286A/S1296A/S1302A/T1305A, MutTAAT for mutation to Ala on S1296A/S1302A, and MutASSA for mutation to Ala on * This work was supported in part by National Institutes of Health Grant HL22682.
X
ABCA1 p.Thr1305Ala 12869555:30:105
status: NEW38 39, Issue of September 26, pp. 37368-37374, 2003 (c) 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. This paper is available on line at http://www.jbc.org T1286A/T1305A.
X
ABCA1 p.Thr1305Ala 12869555:38:208
status: NEW118 Mutation of Thr residues (1286 and 1305) decreases ABCA1 Phosphorylation. WT-mABCA1-FLAG, mABCA1delPEST-FLAG, mABCA1-FLAG mutated to Ala on T1286A/S1296A/S1302A/T1305A (MutAAAA), mutated to Ala on S1296A/S1302A (MutTAAT), or mutated to Ala on T1286A/T1305A (MutASSA), were transiently transfected in 6 wells of HEK-293 cells (2 òe;g of plasmid DNA per well).
X
ABCA1 p.Thr1305Ala 12869555:118:161
status: NEWX
ABCA1 p.Thr1305Ala 12869555:118:250
status: NEW147 ABCA1 mutated on Thr-1286 and Thr-1305 is not degraded by calpain and is not stabilized by apoA-I. WT-mABCA1-FLAG or mABCA1-FLAG mutated to Ala on T1286A/T1305A (MutTSSA) were transiently transfected into HEK293 cells.
X
ABCA1 p.Thr1305Ala 12869555:147:154
status: NEW186 Effect of apigenin (CK2 inhibitor) and H-89 (PKA inhibitor) on ABCA1 phosphorylation. WT-mABCA1-FLAG or mABCA1-FLAG mutated to Ala on T1286A/T1305A (MutASSA) were transiently transfected in 6 wells of HEK-293 cells (2 òe;g of plasmid DNA per well).
X
ABCA1 p.Thr1305Ala 12869555:186:141
status: NEW